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This review on polymorphism is a personal, non-comprehensive view on the field of polymorphism – a
term which is often misused. Indeed, the discussion about polymorphism and related terms is still ongoing
in the area of crystal engineering. This is why we felt it timely to look into the historical development of its
definition and to delimit it. A short introduction to thermodynamic aspects and characterization methods
of polymorphs is given. One chapter is then dedicated to polymorphism of elements and inorganic
compounds, before discussing the term for organic and organo-metallic compounds. Chosen examples are
given each time to illustrate the cases of polymorphism. In the end, the conclusion yields three flow
schemes useful in determining polymorphism for each compound class.
Introduction
The term polymorphism (Greek for ‘‘many forms’’) is,
depending on the communities, associated with different
meanings. For example, in Biology, it can apply to species with
different phenotypes, designating even sexual dimorphism,
lipid polymorphism, nuclear dimorphism and frond dimorph-
ism. In Computer Science, it refers to a programming language
feature which allows to handle data of different types with the
same interface, and in Medicine, the term polymorphism
relates to a signal series seen in an electrocardiogram.
In Chemistry, and this is what we will focus on, the term
means that a solid compound can adopt different forms and/
or crystal structures. The formation of a solid generally
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includes a crystallization step, based on nucleation and
growth. Nucleation is a kinetically controlled process during
which atoms, ions and/or molecules aggregate into small
clusters, first in a reversible way before forming stable nuclei.
The latter are then able to grow into crystallites and crystals. It
is thus easy to understand that in p rinciple, this first
nucleation process can lead the way to different arrangements
of atoms, ions and/or molecules in the solid state, depending
on how the building blocks of the solid meet. Probably all
scientists dealing with solid state compounds and crystals
have experienced that the more one looks for new structures of
a compound, the more one can find. Indeed, while interac-
tions between ions are usually strong, the interactions between
organic molecules can be numerous, and are often weak and
non-directional, allowing thus for many options to combine
with each other into a stable structure.
It is therefore a challenge to predict the solid state structure
of a compound, and many theoretical approaches have been
tested to find more and more successful predictions. For
example:1–7 Indeed, the Cambridge Crystallographic Data
Centre (CCDC) hosts since 1999 approximately every two to
three years the Crystal Structure Prediction Blind Test, a defeat
in principle for every chemist.5,8–11 The results are very
encouraging, yet, Nature holds still enough surprises for us
with unexpected new forms that are found in the solid state.
Polymorphism is not only interesting in the context of basic
science, understanding the concepts of intermolecular inter-
actions, but the industry dealing with materials as well as with
pharmaceuticals, has also a huge stake in this area. For
materials, control over the solid state is crucial for their
physical properties, e.g. conductivity or tensile strength, while
for pharmaceutically active compounds, the form of the solid
state structure can determine its activity or even toxicity.
In March 2013, the Web of Science counts more than
66 000 papers on polymorphism in the areas restricted to
chemistry, pharmacology/pharmacy and materials science.12
The number of publications on polymorphism has increased
dramatically from 393 in 1992 to more than 5400 in 2012,
showing the interest in this research area, but also the
widespread of use of the term ‘‘polymorphism’’ – not always
with the same meaning. This is why this Review starts with a
chapter on the historical development of the term, as well as
the current definitions which can be found in the literature. It
will then give some chosen examples out of each class of
compounds, inorganic/metallic, organic and coordination
compounds, in order to give the scientists first of all an idea
about the types of polymorphisms which may exist, and
second, a handful of tools to decide whether they have or not
themselves cases of polymorphism among their own com-
pounds. This Review is non-comprehensive.
Since the definition of polymorphism has varied greatly
over time and space, let us start by unrolling the story of
polymorphism and finding a definition for ourselves. We will
also highlight different types of polymorphism discussed in
the literature in order to include or exclude them from our
personal comprehension of polymorphism.
A. Polymorphism? History and definitions
Historically, it is Klaporoth in 1788 who identified and
described a first case of a compound adopting several crystal
forms, namely three forms of calcium carbonate: calcite,
vaterite and aragonite.13 In 1832, the first case of polymorph-
ism in an organic compound, benzamide, is discovered by
Wo¨hler & Liebig,14 but it isn’t until 1938 when Robertson &
Ubbelohde find the first X-ray diffraction structure of
polymorphs with resorcinol, and this is, to the best of our
knowledge, the first crystal structure determination of poly-
morphism.15
A1. ‘‘What is a polymorph?’’
To this apparently simple question, the literature provides
numerous different definitions, which are all based on the one
given by McCrone in 1965: ‘‘A polymorph is a solid crystalline
phase of a given compound resulting from the possibility of at
least two different arrangements of the molecules of that
compound in the solid state.’’16 In 1969, Rosenstein & Lamy
propose an alternative definition: ‘‘When a substance can exist
in more than one crystalline state it is said to exhibit
polymorphism.’’,17 which allows an interpretation including
a lot of different forms, for example also solvates. Continuing
the overview of the different definitions found in the literature,
the one given by Burger in 1983 is noticeable: ‘‘If these (solids
composed of only one component) can exist in different crystal
lattices, then we speak of polymorphism.’’18 but as pointed out
by Bernstein, this last definition seems to be unclear about the
terms crystal lattice and crystal structure19 and the possibility
of polymorphism in co-crystals, solvates or salts is excluded.
The more complete definitions are probably given by (i)
Sharma in 1987: ‘‘Polymorphs means the different crystal
forms, belonging to the same or different crystal systems, in
which the identical units of the same element or the identical
units of the same compound, or the identical ionic formulas or
identical repeating units are packed differently’’,20 or (ii) more
recently by Gavezzotti in 2007 with a definition in three points:
‘‘Polymorphs are a set of crystals (a) with identical chemical
composition; (b) made of molecules with same molecular
connectivity, but allowing for different conformations by
rotation about single bonds, (c) with distinctly different
three-dimensional translationally periodic symmetry opera-
tions’’,21 or iii) also by Purojit & Venugoplan in 2009: ‘‘thus it is
defined as the ability of a substance to exist as two or more
crystalline phases that have different arrangements or
conformations of the molecules in the crystal lattice.’’22 In
its recommendation of 1994, IUPAC defines the polymorphic
transition as ‘‘a reversible transition of a solid crystalline
phase at a certain temperature and pressure (the inversion
point) to another phase of the same chemical composition
with a different crystal structure.’’.23
Based on all these definitions, we have now a good idea of
what polymorphism is, but now, it must be defined how to
limit and use the term ‘‘same substance’’ or ‘‘compound’’.
IUPAC, the term ‘‘chemical substance’’ is used for ‘‘a matter of
constant composition, best characterized by the entities
(molecules, formula units, atoms) it is composed of. The
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physical properties such as density, refractive index, electric
conductivity, melting point etc. characterize the chemical
substance.’’23 This definition contains a first contradiction
with polymorphs, as, indeed one of the characteristics of
polymorphs is that they can have different physical properties,
like for example the melting point, solubility or refractive
index. For this reason, we prefer to use the term compound
with the meaning of ‘‘identical chemical composition’’ in this
Review. As a consequence, ‘‘identical chemical composition’’
excludes thus the phenomenon often called pseudopoly-
morphism – a confusing term to define solvates – from the
list of possible types of polymorphism. Indeed, already in
1965, McCrone referred to pseudopolymorphism as a term ‘‘…,
which is convenient to use here but which should never be
allowed to come into general use, is meant a variety of
phenomena sometimes confused with polymorphism.’’.16
We should however point out the fact that the U.S. Food and
Drugs Administration (FDA) uses a wider definition for the
‘‘classification of polymorphs’’. ‘‘Different crystalline forms of
the same substance. This may include solvation or hydration
products (also known as pseudopolymorphs) and amorphous
forms.’’24 For the pharmaceutical industry, pseudopolymorph-
ism is a case of polymorphism, and, more surprisingly,
amorphous forms are also a case of polymorphism. This
broad definition allows to cover 72 different forms for axitinib,
out of which five are anhydrate forms, and among the
remaining 67 solvates, some co-crystals (definition see later
in the chapter) are found.25
Excluding the pseudopolymorphism allowed by the FDA
definition, there remain two cases of polymorphism to be
considered:
The first one is due to the possible rotation about single
bonds in a molecule leading to several possible conforma-
tions, thus called conformational polymorphism. Examples of
conformational polymorphism in the solid state are shown in
Fig. 1, top.
In the second type of polymorphism, the molecules possess
quasi the same conformation, but possess different inter-
molecular interactions, leading to different arrangements
between the molecules. This is then called packing poly-
morphism. An example showing two different packings for the
same compound is shown in Fig. 1, bottom.
It should be noted at this point that generally, polymorphs
are numbered in the order of their discovery. Yet, the labelling
does not follow a terminology rule, and on case uses a, b, c or
I, II, III or a, b, c or 1, 2, 3 to name the different polymorphic
forms. Further examples will be treated in more detail in the
next chapters.
A2. ‘‘Enantiomeric and tautomeric polymorphism’’
These two terms are commonly used but are they to be
considered as real cases of polymorphism or not? Two isomers
interconverting rapidly in solution may be referred to as
polymorphic. Can then tautomers in the solid state also be
classified as polymorphs? These ideas of rapid equilibria and
interconversion are interesting, but in our chosen definition,
compounds with different connectivity between the atoms of a
molecule are different compounds, and hence can be called
isomers, but not polymorphs.
For enantiomers, as well as tautomers, to go from one
enantiomer to another, or from one tautomeric form of the
second, a chemical bond needs to be broken and reassembled
differently. In the case of conformational polymorphism
however, simple free rotations about chemical bonds in the
compounds suffice. From our point of view, enantiomeric and
tautomeric polymorphism is thus not describing a real case of
polymorphism. However, cases of polymorphism with the
same enantiomeric or tautomeric form are of course in
principle possible.
A3. What is concomitant polymorphism?
Concomitant polymorphism relates to polymorphic crystals
that crystallize from the same solution AND under the same
conditions, the latter of which is important and can be
interpreted more or less widely. For example, in the case of
crystallization per evaporation, if one set of crystals appears at
the beginning of the experiment and a second set near the
end, the conditions are very likely not the same as the
concentration depends on the solvent volume and the quantity
of compound in the solution. It is clear that any crystallization,
without variation of the solvent volume, will change the
concentration but small variations in the conditions could be
tolerated in the discussion about concomitant polymorphs.
For more details on this phenomenon of concomitance, we
strongly recommend the review of Bernstein.19,31 The crystal-
Fig. 1 Examples of conformational polymorphism.26–29 Copyright E 2011
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim (top) and packing
polymorphism30 (bottom).
Fig. 2 (a) Morphology of form A of 3-acetylcoumarin. (b) Morphology of the
form A and B at 5 uC depicting concomitant polymorphism. (c) Morphology of
form B at 23 uC. Reprinted with permission from.32 Copyright E2004 American
Chemical Society.
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lization of 3-acetylcoumarin at 5 uC is a nice example of
concomitant polymorphism (Fig. 2).32
A4. What is the limit between co-crystal and pseudo-
polymorph?
Like for ‘‘polymorphism’’, the definition of ‘‘co-crystal’’, or
cocrystal, is still debated in the literature. The first definition
of this relatively ‘‘young’’ term was given by Aarkero¨y33 in 2005
and will serve as basis for the coming discussion: ‘‘Co-crystals
are made from reactants that are solids at ambient condi-
tions’’. All extensions of this definition are focusing on the
starting materials, not on the product. However, some
reactants are liquid at room temperature, and if we follow
Aarkero¨y’s definition in the case of liquid reactants, we would
not observe a co-crystal, but rather pseudopolymorphs or
solvates. We therefore propose to rather use the definition
given by Zaworotko et al. in 2012:24 ‘‘Co-crystals are solids that
are crystalline single phase materials composed of two or more
different molecular and/or ionic compounds, generally in a
stoichiometric ratio, and which are neither solvates nor simple
salts’’. This excludes co-crystallizing solvent molecules and
includes liquid starting materials. It is important to point out
that polymorphism exists also in co-crystals and is an
important issue.
A5. Why so much interest in polymorphs?
Polymorphs are studied in many fields (chemistry, materials,
pharmaceutics sciences…) for their differences in physical
properties. Indeed, polymorphs can have different physical
and thermodynamic properties (density and refractive index,
thermal and electrical conductivity, hygroscopicity, melting
points, solubility, thermal stability…), spectroscopic proper-
ties, kinetic properties (rate of dissolution, stability…), surface
properties (surface area, crystal habit…), mechanical proper-
ties (hardness, compression, thermal expansion…) and che-
mical properties (chemical reactivity, photochemical
reactivity…). For the correct design of a chemical, a material
or a pharmaceutical compound, it is therefore crucial to
control the solid state structure of a compound in order to
guarantee its properties. Such a control may be highly relevant
to life, for example in medicine with pharmaceutical com-
pounds, or in materials science, e.g. in public transport.
One very popular example of polymorphism exhibiting
different colours as a function of the structure, hence the
polymorph, is the 5-methyl-2-[(2-nitrophenyl)amino]-3-thio-
phenecarbonitrile, initially synthesized as an antipsychotic
agent,34 and also known as ROY (for Red, Orange, Yellow)
(Fig. 3),35 which is probably one of the most famous and
surprising compounds with respect to polymorphism. This
compound has been crystallized in ten different polymorphic
forms. It is not the compound with the highest number of
polymorphs, but it is a spectacular compound, which
illustrates perfectly the changes of physical properties.
Depending on the polymorph, different colour and also
different melting temperatures, varying from 94 to 115 uC,
are observed. For more details on this compound, refer to ref.
36
For a very well-known example of solubility differences of
polymorphs, Ritonavir has to be cited (Fig. 4).37 This
compound is an antiretroviral drug, used for treating HIV
infections. After its discovery in 1992 by Abbott Laboratories
and FDA approval in 1996 as a semisolid capsule formulation
and also as a liquid formulation, it failed the dissolution test
in 1998. The precipitated form during this test was identified
as new polymorph Form II, which is less soluble (Table 1) and
thermodynamically more stable than Form I. The drug was
finally commercialized in 1999 after approval of the two forms
by the FDA. More details can be found in the paper by Bauer.38
Some other forms of Ritonavir have also been discovered but
only one is another anhydrous polymorph.39
A6. How to characterize a polymorph
Characterization of polymorphs is an important issue.
Nowadays, scientists have access to plenty of analytical
techniques and some of them are particularly useful to
characterize and determine polymorphism. We will discuss
the most important ones in this paragraph.
The first technique is hot stage microscopy. This method is
used to determine the transition temperature coupled with a
microscope and allows us to identify changes in crystal habit
as well as in light transmission, giving hints on solid state
phase transitions.
Fig. 3 Different crystal forms of ROY. Reprinted with permission from ref. 36.
Copyright E 2010 American Chemical Society.
Fig. 4 Comparison of the two theoretical diffractograms of ritonavir poly-
morphs. (blue) Form I, (red) form II.38
Table 1 Solubility in ethanol/water (mg mL21)40
Ethanol/water 100/1 75/25
Form I 90 mg mL21 170 mg mL21
Form II 19 mg mL21 30 mg mL21
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The second technique is the thermal analysis, regrouping
three techniques: differential scanning calorimetry (DSC),
differential thermal analysis (DTA) and thermogravimetric
analysis (TGA). DSC allows measuring melting points but also
studying the transformation of metastable forms and deter-
mining the relation between the different polymorphic forms.
DTA is similar to DSC, but not as quantitative. TGA allows
monitoring weight changes as a function of the temperature.
This technique is not useful in cases of polymorphism without
changes in the degradation temperature, but is very useful for
characterizing pseudo-polymorphs or solvates.
The third technique relates to spectroscopy, including very
classical techniques like infrared and Raman spectroscopy to
study the vibrational modes of the compound. Also, solid state
NMR can be used for measuring the difference in magnetically
nonequivalent nuclei in two different polymorphs.
The last family of techniques is X-ray diffraction. In this
case, we can also divide the techniques in two different
categories, however not – as may be expected – into powder
and single crystal techniques as structure resolution is
possible with both, but rather into the two categories ‘‘pattern
collection’’ and ‘‘structure resolution’’. In case of X-ray
diffraction pattern measurement, we consider that two
samples are identical if they have the same diffractogram.
Two diffractograms are considered identical when the same
peaks are present (2h ¡ 0.1 to 0.2u) and when the intensity
variations of the same peaks that are smaller than 20%. This
latter requirement can be problematic in the case of oriented
crystal growth and preferential orientation of the crystals. In
order to prevent this, it is thus important to grind the
materials, but with parsimony in order to avoid the increase of
the peak thickness because too broad peaks can be proble-
matic in the peak line identification. In our opinion, the most
efficient method in the polymorph identification is single
crystal diffraction analysis. As Dorothy Crowfoot Hodgkin
argued in her Nobel lecture of 1964: ‘‘The great advantage of
X-ray analysis as a method of chemical structure analysis is its
power to show totally unexpected and surprising structure
with, at the same time, complete certainty’’.
This list of techniques is not exhaustive, and we have chosen
only some popular ones. The important issue in the chosen
techniques for characterizing polymorphs is to eliminate all
possible doubt and for this, usually a combination of
techniques is essential.
A7. Thermodynamic aspects
The nucleation and growth processes are depending on the
thermodynamic properties of the compounds and their
polymorphic forms. The polymorph with the lowest free
energy is the most stable polymorph. This form is called the
thermodynamic form and it differs from the kinetic form
which is characterized by a local minimum of energy. Such a
metastable polymorph is unstable from a thermodynamical
point of view but it has a finite life time, which depends on its
rate to transform into a more stable form and the correspond-
ing activation energy required.
The difference in the Gibbs free energy, DG, determines the
thermodynamic stability of solids and the driving force for a
transformation (at constant pressure and temperature) from
one polymorphic form to a second one. The Gibbs free energy
is defined as the difference between the enthalpy difference
and the entropy difference, as a function of the temperature,
DG = DH 2 TDS. While the enthalpy difference characterizes
the differences in the lattice, hence the energy in the structure,
the entropy difference is related to the lattice vibrations and
the disorder. The sign of DG gives the relative stability of the
system: if DG is negative, the transformation from one form to
another can occur spontaneously, if DG is equal to 0 phases
are at the equilibrium and for a DG positive, the transforma-
tion is not possible spontaneously or without energy input.
Considering three polymorphs a, b and c, as shown in Fig. 5,
the c-form will be the thermodynamic most stable phase. At
the temperature Tt (transition temperature) both polymorphs
a and b have the same energy and consequently they are in
equilibrium. Upon an increase of the temperature, the a-form
will transform into the b-form spontaneously. Inversely, if we
have the b-form and we are on the right side of the transition
point in Fig. 5, a decrease of the temperature will lead to the
transformation from the b- to the a-form. When a pair of
polymorphs like a and b have a transition temperature below
the melting point of the two forms, this pair is named
enantiotropic. However, if a pair of polymorphs, like a and c (or
b and c), has one form, which is more stable at all the
temperatures below the melting point, this pair is named
monotropic. In order to determine if two polymorphs are
monotropic or enantiotropic, DSC or DTA can be used. For the
above example, a DSC measurement with the a-phase as
starting compound will give rise to two endothermic peaks:
The first one will be the transition from a to b, and will give
the transition temperature, while the second peak will be the
melting of the b-form. In contrast, starting from the b-form,
only one endothermic peak will be observed, namely the
melting of b. Finally, if starting from the c-form (the
thermodynamic polymorph), we will also observe only one
peak, the melting of c, whose melting temperature will be
higher than the one obtained before. This experiment model
does not take into account the kinetic aspects of the transition
between the polymorphs, for example fast scan or low
transformation rate. For more details on the thermodynamics
of polymorphs, the interested reader may refer to the papers by
McCrone16 and Bernstein.19
Fig. 5 Gibbs free energy diagram of three polymorphs as a function of the
temperature. (Left) DSC scans as a function of the starting polymorph (right).
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A8. Why this polymorph and not another? Nucleation aspects
As experimentalists, it is sometimes difficult to understand,
why, under apparently similar conditions, one, and not
another, polymorph is formed preferentially, and why some-
times, this preference seems to be inverted without reason.
This has to do with the nucleation processes in solution,
which are reversible to a certain extend.
As said previously, the nucleation is depending on the
thermodynamics, i.e. the free Gibbs energy difference between
the compound in solution and the aggregated compound
determines the crystallization of one form or the other. Let us
consider a simple case of one compound A in solution in an
open crystallization dish and two polymorphic forms A1 and
A2. As time passes, solvent molecules evaporate and the
solution becomes more and more concentrated. Near the
saturation, molecules of A come closer to each other and start
to aggregate. At this point, as a first option, the aggregates
continue to grow and nucleation of A1 occurs, which will give
polymorph A1; or, as second option, the aggregates redissolve
and a second process of aggregation starts. This second type of
aggregation, molecules of A arrange differently than for
aggregation A1, and will give the nucleation of A2, which will
give polymorph A2.
For more information, the interested reader can refer to
papers by McCrone16 Desiraju15 and Bernstein.19
This first chapter has now given the theory for the definition
of polymorphs and related terms discussed in the literature as
well as the thermodynamic bases.
We will now start with examples of polymorphism and how
it can be recognized, in the three different classes of
compounds, which we propose to study in this review, namely
inorganic compounds, organic compounds and metal–organic
coordination compounds.
B. Elements and inorganic compounds
Generally, polymorphism in inorganic chemistry is often
related to different forms of the elements like the many forms
of sulfur, the different carbon structures, like diamond,
graphite, or fullerene or even the different phases a, b, c of a
pure metal (Fig. 6). In this chapter, the allotropism for pure
elements will be discussed with a special focus on the cases of
polymorphism. Furthermore, polymorphism for a few inor-
ganic compounds will also be presented.
B1. Allotropism, polymorphism and co.
One of the first discoveries of ‘‘polymorphism’’ was in reality a
form of what is still called ‘‘allotropism’’ (coined from Greek
‘‘other’’ + ‘‘to turn’’ = other turn, other behaviour). The
allotropism concept was first used by one of the founding
fathers of modern chemistry, Berzelius in 1841.43 At this time,
the allotropy was used to define elements in their different
forms, e.g. for sulphur,44 silicon and carbon (Fig. 6 (left) and
8).
Since this time, it has taken several different meanings: at
the end of the 19th century, Lehmann stated that ‘‘the term
allotropism should be used for any variation of a given
substance, element or compound, that were ultimately trace-
able to variations in the substance’s intermolecular organiza-
tion’’.45 That is to say that all thermally induced changes in
terms of state (liquid, solid, gas, …) or in polymorphism
(isomerism, polymerism) are a form of allotropism.46
Since then, the term ‘‘allotrope’’ was widely used as a
descriptor for phases with identical composition.47 It evolved
with the increasing knowledge and the advancement in
structure determination methods.
At the beginning of the 20th century, Ostwald stated that
‘‘there is really no reason for making this distinction between
polymorphism and allotropism’’48 talking about the distinc-
tion between traditional allotropy (elements only) and isomer-
ism/polymorphism (organic/heteroatomic) for compounds of
the same composition. He was for the abandon of the
distinction between the term allotrope (elements only) and
the term polymorph. This advice was not followed by the
IUPAC and even one century later, the term ‘‘allotrope’’ is still
in use for elements only polymorphism in most chemistry
textbooks49 – and for good reasons. Indeed, in 1987, it was
proposed to define:20 (i) Allotrope as the different forms of the
Fig. 6 (left) Phase diagram (p, T) presenting most of the domains of existence of
the different allotropic forms of sulfur.41 (right) Eight allotropic forms of carbon:
(a) diamond, (b) graphite, (c) lonsdaleite, (d) Buckminster fullerene, (e) and (f)
two other forms of fullerene, (g) amorphous, and (h) nanorods of carbon. The
graphene form, which is the single sheet of graphite, is missing in this scheme.42
Fig. 7 Phase diagram of carbon.54 ECERN.
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same element in which the chemical bonding, and hence the
connectivity, between atoms of the same element is different
and may have different discrete molecular units, irrespective
of the state. (ii) And polymorphs as the different crystal forms,
belonging to the same or different crystal systems, in which
the identical units of the same elements or the identical units
of the same compound, or the identical ionic formulas or
identical repeating units are packed differently.
This means that some allotropes of elements can be
polymorphs, others are not. On the other hand, there are
polymorphs which can refer to the same element. Hence, there
is as an overlap between the classes of polymorphs and
allotropes (Scheme 1).
In summary the main criteria are: (i) For polymorphs:
packing should be different from one crystal structure to
another (comprising elements and compounds). (ii) For
allotropes: the chemical bonding should be different. If the
chemical bonding does not change, then it can be classified
among the polymorphs (comprising elements only, indepen-
dent of the state of matter).
Nowadays, allotropy is defined as:
IUPAC: The property of some chemical elements to exist in
two or more different forms, known as allotropes of these
elements. Allotropes are different structural modifications of
an element.50
From these multiple definitions, it can be seen that the
concept of allotropism has strongly evolved over time. The
allotropy nowadays concerns only the different forms of an
element generally inside the same state of matter (solid,
liquid, gas…). Phase or state transitions of elements are not
necessarily associated with modifications of the allotropic
form, and for some elements, the allotropic forms can exist in
several phases/states.
The term ‘‘transition’’ needs to be defined for allotropes and
polymorphs, as it contains different aspects concerning
transformation and properties:
Thus, for an allotropic transition, we have: A transition of a
pure element, at a defined temperature and pressure, from
one crystal structure to another, which contains the same
atoms but which has different properties.51 And for a
polymorphic transition: A reversible transition of a solid
crystalline phase at a certain temperature and pressure to
another phase of the same chemical composition, but with a
different crystal structure.52
The two definitions are similar because in the first case, the
criterion, i.e. the difference of physical properties, arises
directly from a different crystal structure/packing. In the case
of polymorphs where the crystal structure difference is the
criterion, the crystal structure determines many physical
properties of compounds such as the solubility, crystal shape,
hardness or density. While allotrope transitions are restricted
to elements, the polymorphic transition extends to com-
pounds and hence includes that the atom connectivity should
be the same – a requirement not necessarily met by allotropes.
In the following parts, some general examples of inorganic
allotropes and polymorphs will be presented. The difference
between an allotrope and ‘‘real’’ polymorphs will be shown.
The importance and implications of these polymorphic and
allotropic transitions on properties and applications of
materials will also be made.
B2. Non-metallic allotropes and polymorphs
A systematic overview of the different types of inorganic
allotropes begins with the non-metallic allotropes and the
various and well-known forms of carbon.53
Carbon. Carbon presents many allotropic forms, some of
which can be also considered as polymorphs (Fig. 6 (right) and
7). For example, the adamantane (diamond) belongs to the
cubic system and is an allotropic form of the lonsdaleite which
belongs to the hexagonal system, and it is also a polymorph
according to the definition stated before: same composition,
Fig. 8 Molecular structure of (a) diamond and (b) londsdaleite. Reprinted by
permission from Macmillan Publishers Ltd, Nature,55 copyright E 2003.
Scheme 1 Polymorphs and allotropes.
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two crystalline forms with different packing and same
chemical bonding (Fig. 8).
Starting from graphite, other forms like graphene and
carbon nanorods, as well as fullerenes can be derived, which
are also allotropic forms of the carbon (Fig. 9).56
All of these would in principle also fit the definition of
polymorphs, as each carbon atom is always connected to three
other carbon atoms. There are not a lot of studies actually
focusing on transitions of these ‘‘polymorphs’’ mainly because
they are hard to produce and isolate. One example of the phase
transition of planar 2D-graphene into 3D-folded graphene has
been observed optically.57 This 3D structure can be considered
as a precursor for the formation of nanorods (Fig. 10).
It should be noted that these polymorphs are polymorphs by
definition because their packing is different, while their
connectivity stays the same.
B3 Metallic allotropes
Usually, pure metals adopt one of three preferential crystal
lattices: body centered cubic (BCC), face centered cubic (FCC)
or hexagonal close packed (HCP). These three types of crystal
lattices represent the structures of 90% of the metallic
elements under standard conditions. This arises from the fact
that most of the metals have a coordination number of their
atoms of 8 to 12 and that the structures are built using the
hard sphere model to best fill space (Fig. 11).58,59
The BCC and FCC crystal structures belong to the cubic
crystal system whereas the HCP belongs to the hexagonal
system. In the FCC and HCP system, each metal atom is
surrounded by twelve other metal atoms whereas in the BCC
system, there are only eight neighbour atoms. The atom
packing/density is larger in the two systems, FCC and HCP
(74%), than in the BCC one (68%).58 In terms of polymorph-
ism, related to atom connectivity, it would thus be reasonable
to consider a transition between FCC and HCP as polymorphic
transition, while the one between BCC and FCC or HCP is not.
For example, in the case of the iron, the transition between the
e-ferrite and the c-austenite is a polymorphic transition but the
transition between c-austenite and a-ferrite is not (Fig. 12).
These different crystal structures have a direct impact on the
metal properties. For example, lead (Pb) and gold (Au), which
belong to the FCC lattice, are plastic metals because of the
presence of a lot of planes along which rows of atoms can
slide: the slip planes. In comparison, metals like titanium or
cobalt, which possess an HCP structure with less slip planes,
are harder to deform.61 This property of deformation of metals
under stress is called the plasticity (ductility: tensile stress and
malleability: compressive stress). The metal crystal structure
can however change depending on the conditions, namely
pressure and temperature.
Iron (Maiden): let’s play metal…. A good example of such
metal phase transitions is iron (Fe). The iron manufacturing
Fig. 9 Graphene as ‘‘mother’’ of all graphitic forms. Reprinted by permission
from Macmillan Publishers Ltd, Nature Materials,56 copyright E2007.
Fig. 10 Phase transition of a graphene membrane: graphene sheets, embedded
in a polymer matrix, scroll and fold when heated above the polymer’s glass
temperature. Reprint with permission from,57 Copyright E 2009, American
Chemical Society.
Fig. 11 Common crystal lattices of pure metals: face centered cubic (FCC), body
centered cubic (BCC) and hexagonal close packed (HCP).60
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and processing is an ancient knowledge that was passed on
through the centuries. Nowadays the production of iron and
its derivatives is well understood and controlled, using tools
such as the phase diagram and the transition temperature
point. It is a very good case study for the allotropism of metals
and alloys and is also very important for the industry.
Iron adopts two different packing types upon heating: BCC
(a-ferrite) at low temperature then FCC (c-ferrite) upon
heating, and back to a BCC system (d-ferrite) at even higher
temperature (Fig. 12). This BCC system of d-ferrite has a larger
distance between the iron atoms than the one of a-ferrite.
Since the connectivity of the atoms in these two phases is the
same, they are considered as polymorphs.
Several important modifications of properties arise from
these allotropic/polymorphic transformations. For example,
the cell volume decreases, but the density, the number of
bonds between atoms and the solubility towards carbon
increase from BCC to FCC. The carbon solubility is very low
in the case of the BCC a-ferrite, however in the FCC
c-austenite, it is higher due to the larger distance between
the Fe atoms. Thus, the carbon can be more easily inserted
into the host structure of the FCC lattice.62 By a rapid
quenching of the FCC structure, doped with carbon, the BCT
(body centered tetragonal) forms (a9-martensite) can be
obtained. The connectivity between atoms change between
the FCC and BCT lattice, thus, this transformation is
allotropic. The BCT, body centered tetragonal, lattice can be
seen as a deformed BCC lattice. This deformed BCC lattice of
iron and carbon is commonly called steel or martensite
(Fig. 13).
This leads us to the subject of alloy formation, solid
solutions and, in particular, steel and its processing, into
which we will now make a short excursion.
Alloys/solid solutions – hard as rock: the steel!. The steel and
iron industry is one of the pillars of the industrial develop-
ment and has a huge economic impact on our society since the
Middle Ages and even before. Its manufacturing process and
development are strongly correlated with the allotropic
properties of the iron and its capability to solvate carbon
and many other metals and additives.
One of the most important examples of the use of the
properties of the iron-carbon alloy is the tempering. This
ancient method is employed in forging to improve and fine-
tune mechanical properties (hardness, toughness, ductility, …)
out of a mix of iron with low carbon content by rapid cooling
(quenching) from high temperature. By using this type of
technique, carbon-containing austenite (c-Fe + C) can be
transformed into the metastable phase of carbon-containing
martensite (a9-Fe + C) which yields a very hard steel (Fig. 13
and 14).63,64
The allotropic transformations that occur inside the iron–
carbon alloy are related to the transition that we described for
the iron case. In addition, in the case of theses alloys, two or
more phases can coexist, for example ferrite can coexist with
Fe3C (cementite), and are dependent on the total carbon
content (Fig. 14). The transformations can happen following
two different ways: (i) Slow transformation, which is accom-
panied by diffusion of atoms and the redistribution of carbon
Fig. 12 Phase diagram of pure iron with different packings.41
Fig. 13 FCC, BCC and BCT lattice system of different forms of iron with carbon
insertion.
Fig. 14 Phase diagram of the Fe–C alloy phases: Ferrite: a-Fe + C, Austenite: c-Fe
+ C, Cementite: Fe3C, Combination of phases: Pearlite: a-Fe + C + Fe3C,
Ledeburite: eutectic mixture of c-Fe + C, Fe3C. The a9-Fe + C (martensite)
metastable phase can be found between 0.002% and 2.1% of C content below
the eutectic temperature of austenite.65
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between the phases, which leads to the formation of several
distinct phases. The thermodynamically more stable phases
are formed (slow heating/cooling). (ii) Rapid transformation,
achieved by quick shear or thermal stress mechanisms, which
implies a collective movement of atoms without redistribution
of atoms between phases, which is called displacive transfor-
mation (supercooling). The metastable, kinetic phases can be
obtained in this way. This is in essence the principle of the
quenching/tempering (Fig. 15).
For the Fe–C solid solution/alloy, it has been shown that
allotropic transitions have a strong impact on the final
physical properties of the material: several very important
properties of steel depend directly on these phenomena:
solubility difference of carbon in the different phases of iron,
crystal shape, the morphology and composition of grain and
the physical properties, for examples plasticity, toughness or
hardness depend on it.67
The ‘Devil’s’ metal: the tin (Sn). It has been shown that the
iron–carbon allotropism allows to obtain a stronger material,
the steel, with tunable physical properties. In this paragraph
now, the ‘‘negative’’ effects of allotropism on the properties of
a metal will be presented on behalf of tin. Tin has a historically
interesting allotropism. It is known from the antiquity and was
mainly used in bronze alloys (mix of Cu and Sn). It possesses
several phases and undergoes allotropic transitions. The so-
called tin pest is an allotropic transformation of white (BCT)
b-Sn to grey (FCC) a-Sn.68 The physical properties and the
aspect of the white and grey tin are totally different. The white
tin is ductile, metallic with a silvery shine, while grey tin is
brittle, nonmetallic, darker, less smooth, and it tends to form
a powder (Fig. 16).
This transition from white to grey tin occurs below 13.2 uC.
The kinetic of the transition is relatively slow but once nuclei
of grey a-Sn are already formed and contaminate the white
b-Sn, the kinetic of conversion becomes fast, as an auto-
catalytic process (within several hours up to days for a total
conversion depending on the temperature). Even bronze (an
alloy of Cu and Sn) can undergo a similar process if prolonged
storage at low temperature occurs.69,71 This transition affects
mainly the tin by increasing its unit cell volume and
decreasing its electronic conductivity (Fig. 17).
Some well-known stories relate the effect of this tin pest on
the human activities:72,73
In 1812, the tin buttons on the clothes of Napoleon’s
soldiers were attacked by tin disease and crumbled in the
Fig. 15 Time–temperature transformation diagram or quenching diagram of
steel. Ms corresponds to the starting point of martensite formation and Mf to
the end of the formation. Pearlite: a-Fe + C + Fe3C and bainite: a different
microstructure of the pearlite. Adapted from ref. 66. Copyright E 1999
Metallurgical Consultants.
Fig. 16 (a) aging of an alloy of bronze alloy Cu0.5Sn0.5 stored below 13.2 uC.
69 E
Emerald Group Publishing Limited all rights reserved. (b) A representation of
balls of tin: left white tin and on the right grey tin.70
Fig. 17 Allotropic transition of tin and its effect on the unit cell. It is not
considered a polymorphic transition as the number of neighbor atoms changes.
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harsh Russian winter of 1812. Napoleon was thus unprepared
for the Russian winter ‘‘right down to the buttons’’.
In 1850, Organ pipes made of tin in the old castle church at
Reitz crumbled into gray powder during the winter, one of
many such occurrences in cold northern European Cathedrals.
Before the chemical explanation was available, this was
sometimes attributed to the work of the devil.
In 1912, Captain Robert Scott and his entire expedition to
the South Pole perished. This tragedy has been attributed to an
attack of tin disease. The kerosene for the return journey was
stored in cans soldered with tin. The fuel escaped out of the
cans resulting in the loss of all the lives to the Antarctic cold.
Even today, tin is still widely used, mainly for solder
purposes. In order to fix the allotropic transition problem,
some lead, bismuth and other heavy metals are now added to
form stable alloys.74
From this example, we can conclude that an allotropic
transition can cause important changes in properties like
ductility or conductivity of materials, e.g. changing a conduct-
ing metal into an insulator. The transition in itself is in
principle reversible but the structural/mechanical damages on
the material are not, and integrity is completely lost as in the
case of tin. A video showing the decomposition of a tin block:
http://www.youtube.com/watch?v=sXB83Heh3_c.
After having discussed two cases of allotropy for metals, let
us now turn towards binary compounds, for which also some
examples are chosen.
B4. Ceramics and minerals: the ‘fake’ diamond
Zirconia-based materials are used as a simulant of gems and
diamond,75 as electroceramic,76 and also for dental implants
because of its biocompatibility and high fracture toughness.77
Pure zirconia, ZrO2, however, undergoes a process of unit cell
expansion during its manufacturing process (sintering/heat-
ing).
The ZrO2 crystal system changes from a monoclinic crystal
system at low temperature to a tetragonal one upon heating
and finally ends in a cubic system at high temperature
(Fig. 18).79 This volume expansion causes internal stress
during the cooling process leading to cracks, fractures, and
thus inhomogeneity in the material, which is therefore prone
to major failure.
One solution found to prevent this was to add some yttria
(yttrium oxide) and/or other oxides to the zirconia in order to
fill the voids in the structure and stabilize the tetragonal
metastable form or even the cubic form with a high content of
dopant (electroceramics) (Fig. 19).
By doing this, a polymorphic transformation can be turned
into a useful process. Thus, when cracks form in the
metastable tetragonal material via an external source, the
induced local stress delivers energy to the system and will
trigger the polymorphic transition from the tetragonal to the
monoclinic system, causing a decrease of the unit cell volume
and an overall contraction of the material in the concerned
stress zone. Thus, the crack, an unwanted physical default, is
self-healed by the polymorphic transition and the correspond-
ing volume reduction of the material.82–85
With the zirconia, the impact of polymorphic transforma-
tions on the properties of a simple metal oxide (ceramic) has
been shown. In the following part, two examples of silicates
polymorphism will be presented: the olivine and the perovs-
kite, which play a major role in the geology and geodynamism
of our planet.
B5. The olivine and derivatives (MgFe)2SiO4 and MgSiO3: from
the crust to the core
Olivines and perovskites represent the structure type of the
most abundant minerals on earth.86,87 Olivine polymorphs
with the composition (Mg,Fe)SiO4 are mainly found under the
crust of the upper Earth’s mantle, while the perovskite forms
of composition MgSiO3 can be found deeper in the lower
mantle, down to the boundaries of the outer core (Fig. 20).88
In the upper mantle, the polymorphic transitions of olivine
to more tightly packed structures can be summarized as
Fig. 21.
The first polymorphic transformation of the a- to b-form
relates directly to one of the well-known seismic disconti-
nuities in geology and geophysics at 410 km of depth,
corresponding to 13–14 GPa.91 The next transition from the
b- to the c-form occurs even deeper at 17–19 GPa. At 23–25 GPa
and 660 km depth, a new mineral, perovskite, and oxide are
formed by the disproportionation of Ringwoodite, the c-form
Fig. 18 Polymorphic transformation of ZrO2: changes in lattice and crystal
system view. Reprint from ref. 78. Copyright E 2004, John Wiley and Sons.
Fig. 19 (left) Phase diagram of Zirconia doped with Yttria (m: monoclinic, t:
tetragonal, c: cubic),80 with kind permission from Springer Science and Business
Media (right) and visual representation of the insertion of the yttrium oxide
inside the zirconia oxide lattice.81
11
ht
tp
://
do
c.
re
ro
.c
h
of olivine, under high pressure and temperature, correspond-
ing to another major seismic discontinuity (Fig. 20 (bottom)
and 22).92–94
The perovskite possesses also a polymorphic form. It has
been proven that at even higher pressure near the mantle-core
boundary conditions, the perovskite transforms into a new
polymorph, the post-perovskite (Fig. 23).95 This post-perovs-
kite has a strong influence on the third big discontinuity in the
earth’s mantle, the D99 layer, a 200 km thick layer of post-
perovskite and iron doped species (Fig. 20 (top)).
These three discontinuities are considered as the main
sources of the seismic phenomena and are strongly linked to
the plate tectonic mechanism and also to geomagnetism by
thermal coupling between the core and lower mantle.88,96–98
Silicates such as olivines are based on covalent Si–O bonds
by which each Si-atom is surrounded in a tetrahedral fashion.
Another covalent compound, in which tetrahedral angles play
an important role, is water.
Fig. 20 Radial structure of earth (top) representation of the different layers of
the earth: from the crust to the core with details on wave speed propagation,
pression, depth, general chemical composition, and density (the preliminary
earth model), reprinted from Publication ref. 89. Copyright E 1981, with
permission from Elsevier. (Bottom) a more detailed view: from upper to lower
mantle with indications on mineral composition and seismic velocity and
discontinuity.90
Fig. 21 The two polymorphic transitions of the olivine.
Fig. 22 Scheme of transformation of c-ringwoodite to perovskite.
Fig. 23 Transformation of perovskite into post-perovskite.
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B6. Water/H2O: the many forms of ice
The solid form of water is an interesting case for non-metallic
compounds as it can adopt at least 15 different polymorphic
forms under different temperature and pressure regimes.99 It
should be noted that some of the forms of ice cannot be
directly obtained from liquid water, like the forms II, IV, and
VIII, which are only available through solid-solid phase
transformations.100,101
The number of available structures arises directly from the
molecular water structure. With a 4-coordinated structure, two
hydrogen bond donor and two acceptor functions, the water
packing allows the formation of a lot of possible voids
available for packing rearrangements and, thus, polymorph-
ism (Fig. 24).100
Thus, the form I of ice is the normal phase under standard
pressure. There are at least two crystal systems in which it can
occur: the hexagonal form (Ih), which is common for
snowflakes or lake ice and the cubic form (Ic), which relates
to ice formed by vapor deposition on a solid surface between
2120 uC and 2140 uC. The cubic structure cannot be obtained
by solid-solid transformation of the hexagonal structure using
a simple cooling or compression, like it is the case for some
other phases of ice. The cubic form can transform into the
hexagonal one but the reverse reaction is impossible up to
now. This is due to the fact that the hexagonal nuclei (and unit
cells) are larger than the cubic ones. Thus during crystal
growth, the cubic system is irreversibly lost.102 The cubic form
possesses a slightly higher vapor pressure than the hexagonal
ice form and can be formed naturally in the upper atmo-
sphere.103,104
In conclusion, there are a lot of different polymorphic forms
of ice arising from the particular molecular bonding and the
space availability for packing rearrangements. This is based on
a mix of covalent bonds and hydrogen bonds, the latter of
which are weak, but in the solid state, where they sum up to
overall large interactions, contribute significantly to the
formation of these different structures. Most of these
polymorphs can be distinguished by temperature and pressure
limits in a phase diagram but some of them correspond only
to narrow metastable forms that appear within these well-
defined domains.
While water can be considered as a simple binary and
inorganic compound, it is made of covalent bonds, the latter
of which are at the basis of all organic compounds. Hence, our
next chapter will deal with polymorphism of molecular,
organic compounds.
C. Polymorphism of organic compounds
Polymorphism was introduced and defined in the first
chapter, and in the second chapter the difference between
allotropism and polymorphism has been pointed out. We will
now focus on organic compounds to illustrate conformational
and packing polymorphism with different examples. We will
first focus on axitinib as a case of conformational polymorph-
ism.
C1. Axitinib, an active pharmaceutical ingredient (API)
In the first chapter we have illustrated the ambiguity of some
definitions, especially in the case of active pharmaceutical
ingredients (APIs). In order to illustrate this, we propose here
to study the case of the axitinib. This drug is approved by the
FDA in case of failure of the systemic therapy in the advanced
renal cell carcinoma.
The literature counts 72 forms of axitinib, of which only five
are anhydrous forms, while the others are based on this
compound’s interesting tendency to form solvates. In the list
Fig. 24 Molecular structure of ice I and phase diagram of water/ice.
Reproduced from ref. 101.
Scheme 2 Molecular scheme of axitinib. Hydrogen bond donor sites are
overlaid in red, acceptor sites in green.
Scheme 3 Representation of the aspirin with atoms and torsion angles labeling.
Scheme 4 Schematic representation of paracetamol.
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of solvated forms, some contain the same solvent, e.g. water,
cyclohexanone, acetic acid, isopropyl alcohol, and ethanol, but
in different amounts, and are thus rather pseudo-polymorphs
or solvates. We will focus here only on the anhydrous forms.
The scheme of axitinib (Scheme 2) shows that two potential
hydrogen bond donor and three potential acceptor groups
exist in this molecule. All of the five polymorphs (Table 2)
possess hydrogen bonds between the pyrazole (donor) and the
benzamide (acceptor). However, polymeric forms I and VI have
also hydrogen bonding motifs between the benzamine as
donor and the pyrazole as acceptor, whereas forms IV, XXV
and XLI form hydrogen bonds between the benzamine, also as
donor, and the pyridine as acceptor (Fig. 25).
A simple method to compare the polymorphs, especially the
conformations of the axitinib molecule itself, which allow
these different forms, is to overlay the molecular units of each
of the different crystal structure. Campeta25 carried out this
study and found that we are in presence of conformational
polymorphism. Indeed, if the pyridine group is superposed for
each form, the rest of the molecule is not aligned for each
polymorph (Fig. 26). This visualization is completed by a
comparison of the torsion angles in the molecules for each
polymorph (Table 2).
Based on these differences in the conformation, different
hydrogen bonds are available, and different packings derive
from these conformational changes.
Table 2 Anhydrous polymorphs of axitinib
Form I25 IV105 VI25 XXV105 XLI25
Space group P1 P1¯ P1 P21/c P21/c
a (Å) 7.7400(7) 11.8638(5) 8.1486(4) 4.5427(2) 16.081(2)
b (Å) 11.8815(10) 12.4067(5) 10.7310(5) 11.7504(5) 8.0976(11)
c (Å) 12.1514(11) 15.0007(7) 12.6824(5) 34.8339(14) 15.557(2)
a (u) 65.667(5) 81.74(2) 68.100(2)
b (u) 72.639(7) 81.150(2) 88.312(2) 92.134(2) 112.226(7)
c (u) 76.189(5) 65.985(2) 70.640(3)
Volume/Å3 963.2 1984.7 965.1 1858.1 1875.3
Density 1.333 1.293 1.330 1.382 1.369
MP (uC) 210.5 218.7 211.6 217.2 225.9
N…O (Å) 2.83 2.80 2.82 2.83 2.78
t1 (u) 165,2(8) 174.8(8); 5.9(9) 2.0(8) 171.9(6) 57.2(4)
t2 (u) 159.7(6) 169.9(5); 166.3(5) 172.0(4) 167.9(5) 5.2(4)
CSD code VUSDIX06 VUSDIX01 VUSDIX03 VUSDIX VUSDIX04
Fig. 25 Crystal packing patterns of anhydrous axitinib forms: (a) form I, (b) form
IV, (c) form VI, (d) form XXV and (e) form XLI. H-bonds are drawn as dashed red
lines. Reprinted with permission from.25 Copyright E 2010 Wiley-Liss, Inc.
Fig. 26 Aligned crystallographic molecular conformations of axitinib (form I is in
red, IV in green, VI in blue, XXV in orange and XLI in purple).
Table 3 Crystallographic data for the polymorphic forms of TNT
Monoclinic Monoclinic Orthorhombic
Space group P21/a B2/c Pca21
a (Å) 14.9113(1) 39.81(5) 14.910(2)
b (Å) 6.0340(1) 6.05(1) 6.034(2)
c (Å) 20.8815(3) 14.96(5) 19.680(4)
b (u) 110.365(1) 90.3(5) 90
Volume (Å3) 1761.37(4) 3607 1770.6(7)
Temp. (K) 100 123
Z 8 8
CCDC code ZZZMUC08 ZZZMUC09
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Axitinib is a good example of conformational polymorphism
with big differences in the torsion angles. The second example
of this chapter is not an API but an explosive, the 2,4,6-
trinitrotoluene, this small and simple molecule will be treated
as example of packing polymorphism, while the conformation
of the molecule itself does not change much.
C2. 2,4,6-trinitrotulene (TNT), an explosive polymorph
Originally used as a yellow dye, TNT was discovered by
Wilbrand in 1863106 and used as explosive in the 1900s. Its
energy density of 4.184 MJ kg21,107 is used as standard for
other explosives. Despite a not so great appreciation at the
beginning, TNT is now one of the most popular and widely
used explosive compounds. The great advantage of this
material is its large temperature range of stability. This wide
temperature range is important for the preparation and the
handling in civil (demolition work) and military use.
Nevertheless, in 1950, Ito claimed that three phases of TNT
exist, one orthorhombic and two monoclinic ones (Table 3).108
After long studies, two polymorphs are today listed, a
monoclinic and an orthorhombic one.109 TNT melts around
82 uC, and liquid TNT can be poured into containers without
risk of explosion. However, pouring a melt or a solution of a
compound able to crystallize in different forms can be
problematic. One major property for an explosive material is
the sensitivity to detonation. In order to control if one
polymorph is more stable versus detonation than the other
one, it is important to study the polymorphism of this
compound for a safe utilization.
Each molecule of TNT possesses three nitro groups able to
adopt multiple torsion angles with respect to the aromatic
mean plane. In order to determine if we are in presence of
conformational or packing polymorphism, these torsion
angles need to be compared. Both structures possess two
asymmetric units A and B. Unit A of the monoclinic form is
composed by the atoms C8 to C14 (C1 to C7 for unit B) and in
the orthorhombic form by atoms C1 to C7 (C8 to C14 for unit
B). A comparison of the torsion angles (Table 4) shows that
some slight differences are present, but one can still easily
superpose the monoclinic A unit with the orthorhombic B unit
(and monoclinic B with orthorhombic A) and the difference is
shown to be not very large (Fig. 27). One can conclude that
despite three free rotational nitro groups in the structure, and
two distinct units, it is not a case of conformational
polymorphism. Hence, it should be a packing polymorphism.
In order to validate the case of packing polymorphism, the
difference in the two packing modes becomes evident by a
simple visualization of the packing (Fig. 28). Indeed, still using
these two units A and B, in both structures unit A and unit B
are arranged in line with their identical units, and these lines
are formed by a glide/translation operation (along the a
direction). Nevertheless, the repetitive arrangements of the
lines in the unit cell are different. In the monoclinic form, an
alternation of ABAB lines is achieved, while in the orthorhom-
bic form, it is an ABBA arrangement. This succession of two
lines of B is due to the presence of a two-fold rotation axis
symmetry operation.
The knowledge of these two crystal structures is helpful for
better understanding this case of polymorphism, but not
enough to determine if one polymorph is more dangerous
Table 4 Comparison of torsion angles (u) in the monoclinic and the orthor-
hombic polymorphic forms of TNT
Nitro Monoclinic Orthorhombic
A B A B
2 51.9(1) 38.0(1) 39.7(4) 52.9(3)
4 22.6(1) 33.5(1) 33.7(4) 22.7(4)
6 44.8(1) 58.7(1) 58.3(3) 44.4(6)
Fig. 27 Overlay of the two molecular units (unit A from the monoclinic form (in
red) with unit B from the orthorhombic from (in blue) and unit B from the
monoclinic form (in red) with unit A from the orthorhombic from (in blue).
Fig. 28 Representation of the unit cells of the two polymorphs of TNT. H atoms
are omitted for clarity.
Fig. 29 Typical DSC traces for (a) orthorhombic and (b) monoclinic TNT.
Reprinted with permission from.110 Copyright E 2003, American Chemical
Society.
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than the other. To determine which form is the more stable
one, some tests have been performed by e.g. DSC measure-
ments. The DSC traces shows in the two cases an endothermic
peak at 84 uC corresponding to the melting of the TNT, but in
the case of the orthorhombic TNT (Fig. 29), one can also
observe another endothermic peak a few degrees below the
melting point. This peak corresponds to the transformation of
the orthorhombic phase into the monoclinic phase. From
these measurements, it can be concluded that an enantio-
tropic couple of polymorphs is present and that the mono-
clinic phase is the more stable one. Calculations show that the
energetic difference between the two lattices is ca. 0.6 kcal
mol21.110
As mentioned previously, earlier studies have identified
three phases: two monoclinic and one orthorhombic
phases.108 After studies of crystallization in different solvents
and Laue diffraction on these different crystals, Gallagher and
Sherwood have reported that the second monoclinic unit cell
found by Ito was in reality a monoclinic twin crystal. The twins
are related by a rotation around an axis perpendicular to the
plane (100).111
For more details on polymorphism of TNT, see ref. 110, 112–
115.
The second example of packing polymorphism is again an
API, namely aspirin. This simple compound is used and has
interested the scientific community for a long time. Recently,
the discussion was vivid in the literature, when a new form of
aspirin was claimed to be found, as we will discuss in the
following.
C3. Aspirin, so old and so new
Acetylsalicylic acid, aspirin, was first synthesized and isolated
by Hoffman in 1897 (Scheme 3).116 However, aspirin has been
used for a long time, as the compound is extracted from
plants, especially from willow and spiraera. From the
antiquity, this compound is known to help relieve pains,
fevers and headaches. A description for its decoction from
3200 BC has been found in the Ebers papyrus from 1550 BC.
Hippocrates also described the use and properties of powders
made from Willow bark and leaves.
The first crystal structure of aspirin was reported by
Wheatley in 1964,117 while in 2005, Peterson and Zaworotko
reported a new structure for this compound. The first new
form by Peterson and Zaworotko (IIPZ) crystallizes in the
monoclinic space group P21/n with an R-value of 10.8. Since
then, many other resolutions of the same phase were
reported.118 In order to best compare the unit cells found for
the two forms, the ones determined with similar R value will
be used, hence the one based on the crystal data of
Desiraju.119,120 From Table 5, it can be seen that the two
polymorphs have the same space group but clearly different
unit cells. Comparing the molecular geometry of the two
forms, slight differences in terms of torsion angles are
observed. The dimer121 formed by the hydrogen bonds
between the carboxylic groups remains intact with a graph
set R22(8) (red circle in Fig. 30).
122 The two forms have also the
same hydrogen bonds between the methyl group (C9) and the
O4 of the acetyl group forming a C(4) chain (green circle in
Fig. 30). These two hydrogen bonds form a succession of
C(4)R22(8) motifs, hence a chain of dimers. However, one can
detect a simple but important difference in the hydrogen
bonding motifs. This difference is a third hydrogen bond in
form I, based on a R22(8) motif (plum circle in Fig. 30), which
connects the dimer chains C(4)R22(8) together to form a 2D
hydrogen-bonded sheet structure, which is absent in form II.
After the first publication of the form II of aspirin, the
problem of data quality has been raised. Indeed, the reported
crystal structure had bad parameter values (R1obs = 0.162,
wR2obs = 0.308, 2hmax = 40u) and no anisotropy refinement.
These values created a debate discussing the question if that
‘‘new’’ form was real or a determination error of the unit cell.
This example points out the fact that, in polymorphism, and in
general in Science, one technique is usually not enough to
determine and prove with certainty that a new polymorphic
form is observed. Spectroscopic methods and thermal analyses
are also possible and should be used to fully characterize the
compound (see first chapter for list of possible analytic
techniques).
For more details on the polymorphism of aspirin see ref.
118–120, 123, 124.
To conclude this part on organic compounds, a last organic
compound, an API, will illustrate that X-ray single crystal
diffraction is not the only possible tool and shows that a
combination of different tools is important.
Table 5 Comparison of the two aspirin polymorphs obtained by Desiraju119,120
Form I II IIPZ
Space group P21/c P21/c P21/c
a (Å) 11.2776(2) 12.1515(10) 12.095(7)
b (Å) 6.5517(1) 6.5064(5) 6.4991(4)
c (Å) 11.2741(2) 11.3677(9) 11.323(6)
b (u) 95.837(1) 111.574(3) 111.509(9)
Volume/Å3 828.70(2) 835.79(12) 827.1(8)
Temp. (K) 123(2) 180(2) 100(2)
R (%) 2.55 2.9 10.8
t1 (u) 82.2(1) 83.9(2) 84(2)
t2 (u) 3.9(1) 3.7(2) 5(2)
t3 (u) 1.8(2) 1.3(2) 2(1)
D…A (Å) in dimer 2.641(1) 2.635(2) 2.63(1)
Melting point (uC) 143.9 135.5 135.5
CSD Code ACSALA14 ACSALA15 ACSALA13
Fig. 30 Packing of the molecular structure of the two polymorphs of aspirin,
form I (left) and from II (right). Hydrogen-bonds are drawn as blue dashes or
plum lines. Red circles show the R22(8) motif, green circles the C(4) motif and the
plum circle the R22(8) motif.
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C4. Paracetamol: PXRD and DSC as tools
The acetaminophen, or paracetamol (the name comes from
letters of each part of the scientific name: para-acetylamino-
phenol) is a very commonly used drug as analgesic and
antipyretic (Scheme 4). This drug is commonly known to have
two polymeric forms I and II, one monoclinic (I) and one
metastable orthorhombic form (II). The two crystal structures
are known since 1976125 and 2004,111 but in 1982, Burger has
mentioned the existence of a highly metastable form III.126
One of the problems encountered by the pharmaceutical
industry with paracetamol is its compression into tablets.127
This problem of compressibility is due to the packing of the
molecules in the crystal structure, especially due to the
hydrogen bonding motifs in form I. In this monoclinic form,
the paracetamol molecules are packed in waves, in contrast to
the form II (Fig. 31). In form II, the molecules form flat
hydrogen bonded sheets. While these sheets are easily
compressible, form II is difficult to isolate. For the moment,
a wet granulation step is used for the compression of the form
I. The question arose thus if one can isolate the third
polymorphic form and if it is compressible.128,129
An amorphous form of paracetamol can be obtained by
heating of form I (commercially available form) to 190 uC and
rapid cooling to 25 uC at a cooling rate of 100 uC min21.
Depending on the publication,130–134 this form is called glass,
glassy or amorphous form. Under DSC (Fig. 32 top) as well as
the hot-stage microscope (Fig. 33),135 the crystallization from
the glass to the form III at ca. 75 uC can be observed, followed
by the transition to form II around 140 uC and finally the melt
at 159 uC. The form III is only isolated during heating of the
Fig. 31 Packing of the form I and II of the paracetamol, some hydrogen atoms
are omitted for clarity.
Fig. 32 DSC traces of the paracetamol (top) and temperature dependent PXDR
(bottom). Reprinted from Publication.135 Copyright E2007, with permission
from Elsevier.
Fig. 33 Hot stage microscope view of the paracetamol as a function of
temperature. (a) Glass form, (b) Form III, (c) From II and (d) melt. Reprinted from
Publication.135 Copyright E2007, with permission from Elsevier. Video film is
available in the supplementary materials of.135
Table 6 Comparison of the two diphenyl ether polymorphs138
Form I II
Space group P21/n P21/c
a (Å) 9.961(4) 12.1515(10)
b (Å) 8.022(3) 6.5064(5)
c (Å) 12.274(5) 11.3677(9)
b (u) 106.993(6) 111.574(3)
Volume (Å3) 938.0(2) 835.79(12)
Temp. (K) 250(2) 180(2)
R (%) 5.4 2.9
t1 (u) 88.39(7) 87.60(4)
t2 (u) 117.9(1) 118.3(1)
Number of C–H…p (Å) 4 5
CSD Code RAFFIO01 RAFFIO
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glassy form from ambient to the melting temperature. With
this technique, set up by Burley, solid state 13C and 15N-NMR
spectra and powder diffractograms as a function of the
temperature (Fig. 32 bottom) could also be measured.135
Based on this data, the three polymorphs can be classified
from a thermodynamic point of view. The Form I is the most
stable and it is monotropic with any of the two other forms.
Forms II and III are enantiotropes, as the transition from III to
II takes place before the melting temperature. We also remark
that the melting temperature is different for form I and form II
with a higher temperature (170 uC) for the stable form.
This example points out the fact that DSC is a powerful tool
to determine stability range temperature and transitions from
one phase to another. It shows also the fact that DSC can be
used to define a method for isolating a highly metastable
polymorph. The paracetamol history highlights also that
temperature dependent powder X-ray diffraction can be used
to determine the phase and also the structure. Indeed, the
crystal structure of the paracetamol Form III was determined
by resolution of the diffractogram. In order to measure the
diffractogram of the form III, Perrin had sealed an air-free
capillary with form I, and applied a double thermal cycle in an
incubator. After an experiment of 80 h, the obtained pattern is
still the same, which shows that form III is stable enough in an
air-free capillary.136
For more details on paracetamol see ref. 131, 135–137.
C5. ‘‘Funny’’ cases
High boiling point solvent crystallization. Crystallization in
a capillary can be used for studying solvents in their solid
forms. In 2004 Choudhury and Guru Row published two
structures obtains by crystallization of diphenyl ether in
capillary.138 Crystals were obtained by cooling a capillary full
with solvent at different temperatures. The two structures
obtained are packing polymorphs: Form I crystallizes in the
monoclinic space group P21/n, form II in the orthorhombic
space group P212121 (Table 6). Indeed, the conformation of the
two forms is extremely similar with angles between the two
phenyl planes 88.39(7)u and 87.60(4)u, respectively for form I
and II. Differences in the packing modes of the two forms are
due to intermolecular C–H…p interactions (Fig. 34). In form I
molecules form a 3D network, in form II molecules form
tetramers connected linked together by other C–H…p interac-
tions. For more information, we advise you to refer to ref. 138.
Polymorphs with co-crystallizing agent. Research of new
crystalline forms is extremely intensive with APIs, and new
crystalline forms of fluconazole are also investigated (Table 7).
This compound known since 1983 is an antifungal drug with
at least twelve different crystalline forms: anhydrous, solvates,
salts and co-crystals. During their investigations in co-crystals
formation, Choudhury et al. have obtained four new anhy-
drous forms of fluconazole, two monoclinic (4 and 6) and two
orthorhombic forms (5 and 7).139 These four polymorphs can
Fig. 34 (a) Packing of diphenyl ether molecules in form I. (b) Packing of diphenyl
ether molecules in form II. Cg1 and Cg2 are the centroids of two phenyl rings
C1???C6 and C7???C12. Reprinted from Publication ref. 138. Copyright E2004,
with permission from American Chemical Society.
Table 7 Comparison of the fluconazole polymorphs139,140
Form 1140 4139 5139 6139 7139 Monohydrate140
Space group P1¯ P21/n Pbca C2/c Pbca P1¯
a (Å) 7.4992(1) 6.6985(4) 12.9282(9) 27.4726(9) 10.9186(9) 5.6258(1)
b (Å) 7.7869(1) 27.3858(19) 6.0241(5) 10.9196(4) 22.3367(18) 11.7373(2)
c (Å) 11.9817(2) 15.2898(11) 34.834(3) 22.3424(12) 22.3619(17) 12.3063(3)
a (u) 84.947(1) 90 90 90 90 71.235(1)
b (u) 84.625(1) 90.319(3) 90 125.337(2) 90 79.871(1)
c (u) 75.894(1) 90 90 90 90 84.383(1)
Volume (Å)3 674.05(2) 2804.8(3) 2712.9(4) 5467.6(4) 5453.74(8) 756.68(3)
CSD Code IVUQOF IVUQOF IVUQOF IVUQOF IVUQOF IVUQIZ
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be classified as conformational polymorphs due to the large
difference of the molecular conformations. These new forms
are only available via this route of crystallization, while
seeding of saturated solutions of Fluconazole in the same
solvent systems but without the respective co-crystallizing
agent results in the formation of the anhydrous or the
monohydrate form (Fig. 35). However, all forms can be
reproduced with the same solvent systems and co-crystal
former proportions. For more information refer to ref. 139.
The last part of this review will be focus on organo-metallic
compounds, but before illustrate polymorphism with exam-
ples, it is important to define and delimit some new terms.
D. Organo-metallic polymorphs
D1. Definitions
Polymorphism for organometallic compounds is more difficult
to define properly compared to purely organic compounds (see
section C). As it is explained in the textbook Crystal
Engineering, ‘‘a pair of coordination compounds can have
the same chemical formula but different structures. […] In
these compounds, concepts such as ‘‘same chemical sub-
stance’’ or ‘‘same molecule’’ are not always clear.’’15 The
definition of polymorphs is thus a big issue. For example,
Bernstein, in his book ‘‘Polymorphism in Molecular
Crystals’’,19 says: ‘‘The ‘‘safe’’ criterion for classification of a
system as polymorphic would be if the crystal structures are
different but lead to identical liquid and vapour states.’’ This
definition is too wide because, according to this definition,
solvates, organo-metallic isomers and tautomers would be
polymorphic even if they are pseudo-polymorphs or, worse,
not even the same compound. Besides, compounds which
decompose before the melting point will not be considered.
In contrast to the definition of Bernstein, Moulton &
Zaworotko explained that when a superstructure is different
due to the solvent or a guest molecule, polymorphism is an
inappropriate term, which is in agreement with the definition
of Gavezzotti: ‘‘Polymorphs are a set of crystals (a) with
identical chemical composition; (b) made of molecules with
same molecular connectivity, but allowing for different
conformation by rotation about single bonds, (c) with
distinctly different three-dimensional translationally periodic
symmetry operations.’’.21,141 For organo-metallic polymorphs,
Gavezzotti’s definition of polymorphism21 will be considered
as most suitable since this definition does not leave room for
ambiguities but includes all compounds.
Not only solvates or host/guest complexes need to be looked
at with care. Another prominent example are optical isomers
concerning their chirality. The simplest optical isomers in
organometallic compounds are metal ions coordinated with
three bidentate ligands. Two enantiomers are available: D
(delta) and L (lambda) complexes. To differentiate them, the
3-fold axis of the octahedron needs to point towards the
reader. If the ligands then form a right-handed helix, this
complex is defined as D and if the ligands form a left-handed
helix, the complex is defined as L. The D or L complexes are
identical concerning the connectivity between metal ion and
ligands. Here, only the relative positions of bidentate ligands
are different as shown in Fig. 36 for
tris(ethylendiamine)cobalt(III) (Table 8).142 The packing of
both enantiomers is the same but the D-enantiomer cannot
be obtained by torsion, rotation or another degree of freedom
from the L-enantiomer. To transform one enantiomer into the
other, bonds need to be broken and rebound at another
position (Fig. 37). Hence, optical isomers are not polymorphs
Fig. 36 L-Tris(ethylendiamine)cobalt(III)143 and
D-tris(ethylendiamine)cobalt(III).144 Hydrogen and chlorine atoms are omitted
for clarity.
Fig. 35 Raman spectra of the polymorph 4 (black), polymorph 5 (red),
polymorph 6 (blue), polymorph 7 (light green), and fluconazole monohydrate
(pink). Reprinted from Publication ref. 139. Copyright E2012, with permission
from American Chemical Society.
Table 8 X-ray data for the two isomers
Form L form143 D form144
Space group P3¯c1 P3¯c1
a (Å) 10.75 10.81
b (Å) 10.75 10.81
c (Å) 15.50 15.54
a (u) 90.00 90.00
b (u) 90.00 90.00
c (u) 120.00 120.00
Volume (Å3) 1572.71 1550.36
CSD code IRIRAC IRIRAC01
19
ht
tp
://
do
c.
re
ro
.c
h
according to the definition of Gavezzotti. So, a simple way to
determine whether a compound is a polymorph of another
compound is to find out if one or more bonds need to be
broken to obtain the other compound.
D2. Conformational and packing polymorphism
On the basis of conformational and packing polymorphism,
organo-metallic polymorphs can be distinguished in the same
way as organic polymorphs, with one big difference: the
organometallic bonds, especially the bond between an
aromatic ring, e.g. a cyclopentadienyl moiety, and a metal
ion by the center of the aromatic system (Scheme 5). This bond
is defined to be a single bond. As for organic polymorphs, then
two kinds of organometallic polymorphs can be distinguished
for such compounds in a first step: conformational poly-
morphs and packing polymorphs.
Conformational polymorphism. For conformational poly-
morphs, two different types can be found. The first one is due
to the different position of ligands relative to each other.
Ferrocene, which has in total three polymorphs145 is a nice
example for this kind of polymorphism since only the relative
position of the cyclopentadienyl anions is different (Fig. 38
and Table 9). This difference can be very small (less than 10u)
but results in a very different packing as shown in Fig. 38,
starting from the eclipsed conformation (IA II). Another 170u
turn results in the staggered conformation (II A III) and in a
packing which only differs from form II in the space between
the ferrocene units (Fig. 38, Table 9).146 The different
polymorphs of ferrocene are due to phase transitions. The
eclipsed ferrocene transforms into the near to eclipsed
ferrocene at 164 K, and the latter adopts the staggered form
at 242 K.
Other types of conformational polymorphism are due to a
difference in the conformation of the ligand itself. Especially
flexible ligands can have different conformations according to
internal rotations, torsions, etc. The conformation of the
ligand does neither influence the connectivity between the
metal ion and the ligand nor the relative position to the metal
ion. One such example is the chloro[tris(2-
cyanoethyl)phosphine]gold(I) (Table 10).147 An overlay of the
two existing polymorphs easily shows the conformational
changes of the ligands (Fig. 39).
Packing polymorphism. Packing polymorphism can be
defined as polymorphs consisting of exactly the same complex
(same angles, torsions,…) but which are packed in different
ways. In a carboxylated derivative of ferrocene, which exists in
three different packings, this polymorphism becomes evident
(Fig. 40, Table 11).148 The commercial powder of this
compound contains the two first polymorphs. The first one
is favored kinetically but the second form is thermodynami-
Fig. 38 Change in the relative position of the cyclopentadienyl anions and the
resulting packing. Hydrogen atoms are omitted for clarity.
Scheme 5 Two different ways to draw a bond between a metal ion and an
aromatic ring system.
Fig. 37 Transformation from L to D configuration with a molecular model kit.
Table 9 X-ray data for the three polymorphs of ferrocene
Form I II III
Space group Pnma F1¯ P21/a
a (Å) 6.99 20.98 10.56
b (Å) 9.00 15.04 7.60
c (Å) 12.20 11.45 5.95
a (u) 90.00 89.52 90.00
b (u) 90.00 120 121.02
c (u) 90.00 90.58 90.00
Volume (Å3) 766.50 3127.18 409.25
CSD code FEROCE24 FEROCE16 FEROCE01
Table 10 X-ray data for the two polymorphs
Form I II
Space group P21/c P21/c
a (Å) 8.56 11.76
b (Å) 7.9 7.99
c (Å) 19.03 13.42
b (u) 99.82 95.75
Volume (Å3) 1278.67 1254.05
CSD code LESNOM01 LESNOM
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cally more stable. The second form can be ‘‘transformed’’ into
the first polymorph by recrystallization from acetic acid or by
adding and removing ammonia. The third form is only
obtained by crystallization at low temperature.149
D3. Polymorphs of coordination polymers
Coordination polymers are organometallic compounds that
can go to ‘‘infinite’’ in one, two or three dimensions.150
According to this definition, they can be seen as supramole-
cular compounds, which form a ‘‘family’’ with all the metal–
organic frameworks (MOFs), also referred to as metal–organic
coordination networks (MOCNs). The assembly of defined
organic molecules and metal ions as building blocks for
coordination polymers can often take place in different ways
and can thus produce supramolecular isomers.
In this kind of isomers, it is possible to find polymorphs. In
fact, all polymorphs of coordination polymers are supramole-
cular isomers but the reverse is not always true.141 For the
definition of ‘‘polymorphism’’, it is important to make the
difference between a polymorph of coordination polymer and
a supramolecular isomer that is not polymorphic. With the
definition of Bernstein,19 all the MOFs and MOCNs which
decompose before to melt made from the same ‘‘building
blocks’’ cannot be polymorphs. According to the more
restrictive definition of Gavezzotti,21 all these compounds
can be investigated for polymorphism. An illustrating example
for the importance of the chosen definition was published in
2005 by our research group.151 The title of this publication
‘‘Concomitant crystallization of two polymorphs – a ring and a
helix: Concentration effect on supramolecular polymorphism’’
already shows the problem. It is impossible to obtain a helix
from a ring without breaking any bond. At the time, we based
our use of the term ‘‘polymorphism’’ on the same chemical
formula and the same connectivity between the atoms, and in
this definition, we used the term correctly. Yet, the dimen-
sionality of a ring is different (0D) from the one of a helix (1D).
Hence, they are rather supramolecular isomers and not
polymorphic coordination polymers following the definition
of Gavezzotti.
Coordination polymer polymorphs can be differentiated in
the same way as other organo-metallic polymorphs into
conformational and packing polymorphs (see section D2). In
a 1D coordination polymorph, a lot of shapes can be adopted
by one ligand and one linearly coordinated metal ion as shown
in Scheme 6. However, in this kind of polymorphism, the
quantity of solvent molecules and the connectivity (or not) of
counter-ions has to be verified carefully, especially the often
omitted molecules for clarity (often solvent molecules), to
clearly decide if it is true polymorphism or not.
A nice example of conformational polymorphs is given by
Lee & Wang with the [1,4-bis(3-pyridyl)-2,3-diazo-1,3-buta-
diene]-dichloro-Zn(II) polymers (Fig. 41, Table 12).152
Another example was previously realized in our group with
silver ions and the ethanediyl bis(isonicotinate) ligand (Fig. 42,
Table 13).153 This example shows perfectly the shapes I and II
of Scheme 6.
However, for other cases, the difference can be less visible as
explained previously. For example, two helices of trifluoro-
methane sulfonate [2,3-dipyridyl keton]silver(I) are poly-
morphs with the difference being the density of the packing
as shown in Fig. 43 and Table 14.154
For coordination polymer polymorphism, the second type of
polymorphism based on the different packing of identical
Fig. 39 (top) Two polymorphs of chloro[tris(2-cyanoethyl)phosphine]gold(I)
with different ligand conformation; (bottom) overlay of the two polymorphs.
Hydrogen atoms are omitted for clarity. Adapted from ref. 147. Copyrights E
1994, IUCr.
Fig. 40 The single complexes of derivative of ferrocene cannot be distinguished
but the packing is completely different. Hydrogen atoms are omitted for clarity.
Adapted with permission from ref. 149. Copyright E 2004 American Chemical
Society.
Table 11 X-ray data for the three polymorphs
Form I II III
Space group P21/c P1¯ P1¯
a (Å) 8.40 7.42 7.92
b (Å) 8.91 7.81 14.38
c (Å) 14.19 18.12 14.61
a (u) 90.00 98.79 110.68
b (u) 90.41 91.07 90.07
c (u) 90.00 97.21 94.78
Volume (Å3) 1062.54 1029.06 1549.2
CSD code FEROCA FEROCA12 FEROCA13
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substructures is rare. A nice example is the reaction of zinc
bromide with 2,5-dimethylpyrazine (Fig. 44, Table 15), which
can perfectly illustrate this kind of polymorphism. Both
polymorphs are obtained in the same way but the first form
is more stable.155
D4. Solvates as precursors
As explained before, the first test for polymorphism is the
investigation of the chemical bonding, the solvent molecules
and the counter-ions. Even if solvates are not polymorphs with
desolvated compounds, they can act as precursors for
polymorphs. In some cases, a solvate can be heated to remove
Fig. 41 Changes in the relative position of 1,4-bis(3-pyridyl)-2,3-diazo-1,3-
butadiene. A slight torsion of the ligand gives yield to two polymorphs of a
coordination polymer. Hydrogen atoms are omitted for clarity.152 Copyright E
2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Fig. 42 No changes in the ligand conformation but only in relative position of
the ligand. Hydrogen atoms are omitted for clarity. Reproduced from ref. 153.
Fig. 43 Two polymorphs of trifluoromethane sulfonate [2,3-dipyridyl
ketone]silver(I) represented in two styles: spacefilling model on the extreme left
and right, and ball and stick representation in the middle; Hydrogen atoms and
trifluoromethane sulfonate anions are omitted for clarity. Reproduced from ref.
154.
Scheme 6 Schematisation of 1D coordination polymers made of one flexible
ligand with a metal ion of coordination number CN = 2. In I and II the ligand
does not change its conformation. In III the ligand changes its conformation.151
Copyright E 2005 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Table 12 X-ray data for the two polymorphs
Form I II
Space group P21/n Pna21
a (Å) 9.18 7.97
b (Å) 14.60 21.47
c (Å) 10.37 8.25
a (u) 90.00 90.00
b (u) 98.23 90.00
c (u) 90.00 90.00
Volume (Å3) 1374.14 1410.81
CSD code DEMVAT DEMVAT01
Table 13 X-ray data for the two polymorphs
Form I II
Space group P1¯ P21/n
a (Å) 6.16 11.67
b (Å) 8.90 11.07
c (Å) 14.44 12.18
a (u) 93.15 90.00
b (u) 99.90 99.02
c (u) 91.43 90.00
Volume (Å3) 777.62 1555.16
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solvent molecules in order to yield a polymorph of an
anhydrous compound (Table 16).156 During heating, the
solvent molecules ‘‘leave’’ the compound, while the newly
formed polymorph maintains the conformation and relative
position of the ligands around the metal ion of the solvate
(Fig. 45).
D5. Conclusions
Examples for all types of organometallic polymorphs were
discussed in an as simple way as possible, which, however,
sometimes is not easy due to the different definitions. Thus, a
solvate can be a polymorph of another solvate if, first of all, the
number of solvent molecules is the same and, secondly, the
connectivity of solvent to the complex is identical. In the same
way, a salt can form polymorphs as well. The determination of
polymorphism for a salt, a solvate, etc. can be determined in
the same way as for the herein discussed organometallic
compounds.
E. Conclusions
Polymorphism is a very important phenomenon not only in
basic research, but certainly in pharmaceutical industry and
materials science. Polymorphs possess different properties, for
instance the solubility or the mechanical resistance can differ
dramatically from one polymorph to the other – properties
which can be crucial for their application. Hence, it is
important to be able to control the formation of polymorphs
and to understand their formation. We here gave some
insights into the basic knowledge of polymorph formation
and their identification and characterization in order to give
an overview on the current state of the art. Depending on the
compound classes, examples of polymorphs were given.
Particularly for organic compounds, there seems to be a large
number of polymorphs possible if for example many hydrogen
bonds can be formed between the individual molecules. Thus,
for many compounds and depending on the external condi-
tions, there may just as well be still a number of polymorphs to
be discovered – depending on how much time and energy we
spend searching for them. One might think here of research
Fig. 44 Two polymorphs of [ZnBr2(2,5-dimethylpyrazine)]. Hydrogen atoms are
omitted for clarity. Adapted from ref. 155. Copyright E 2009 WILEY-VCH Verlag
GmbH & Co. KGaA, Weinheim.
Fig. 45 The solvate 1a forms solvent-free 1b by gentle heating, which is a
polymorph of 2. Hydrogen atoms omitted for clarity. Adapted with permission
from ref. 156. Copyright E 2005) American Chemical Society.
Table 14 X-ray data for the two polymorphs
Form I II
Space group P21/c P41212
a (Å) 9.54 10.24
b (Å) 12.44 10.24
c (Å) 13.32 28.11
a (u) 90.00 90.00
b (u) 105.17 90.00
c (u) 90.00 90.00
Volume (Å3) 1526.68 2944.43
CCDC code 271 230 271 231
Table 15 X-ray data for the two polymorphs
Form I II
Space group Pnma C2/c
a (Å) 6.27 16.15
b (Å) 10.32 6.49
c (Å 14.38 9.88
b (u) 90.00 115.10
Volume (Å3) 930.42 937.29
CSD code DOPYIR DOPYIR01
Table 16 X-ray data for the solvate and the two polymorphs
Form Solvate I II
Space group Cmcm P21/m Ibam
a (Å) 16.96 9.06 7.92
b (Å) 6.24 7.40 11.49
c (Å) 7.28 5.60 7.78
b (u) 90.00 99.48 90.00
Volume (Å3) 770.27 369.98 707.60
CSD code — — KELCIN
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being done under extremely high pressure or, on the contrary,
in space.
In order to give interested readers a tool in hand to test
their compounds for polymorphism, we established a series of
flow sheets to follow, depending on the class of compounds,
hoping that they are useful for many scientists who are not so
well acquainted with polymorphism. The Schemes 7–9 resume
thus the identification steps for polymorphs. It should also
help to use the term polymorph correctly in order to reduce the
number of publications in which this term is not used in a
correct way.
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